| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/17/2004 | US20040116400 Compounds, compositions, and methods |
| 06/17/2004 | US20040116395 Combinations for the treatment of inflammatory disorders |
| 06/17/2004 | US20040116387 thyroid receptor ligands, preferably antagonists for the treatment of cardiac and metabolic disorders, such as cardiac arrhythmias, thyrotoxicosis, subcllinical hyperthyrodism and liver diseases |
| 06/17/2004 | US20040116380 enhance a host's immune defense mechanisms to infection but do not induce an inflammatory response |
| 06/17/2004 | US20040116369 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 06/17/2004 | US20040116355 Caspase inhibitors and the use thereof |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | US20040116344 Immunomodulatory properties of bip |
| 06/17/2004 | US20040116336 Peptide derivatives |
| 06/17/2004 | US20040116333 Administering to the individual a multimeric compound that binds to at least two P-Selectin Glycoprotein Ligand 1 (PSGL-1) proteins on the surface of a T cell to induces a signal transduction pathway that results in the death of the T cell |
| 06/17/2004 | US20040116328 Condensed imidazole derivatives |
| 06/17/2004 | US20040115809 Propagating cytotoxic lymphocytes with specific toxicity in the presence of antigen presenting cells for use in treatment of tumors and viral infections; immunotherapy |
| 06/17/2004 | US20040115773 Serpin in bifidobacteria |
| 06/17/2004 | US20040115761 Polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040115622 Mixture of peptides originating from a Nef protein and applications thereof |
| 06/17/2004 | US20040115233 Composition for improving skin environment and clothes thereof |
| 06/17/2004 | US20040115221 Intracellular delivery vehicles |
| 06/17/2004 | US20040115220 Vaccine |
| 06/17/2004 | US20040115216 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 06/17/2004 | US20040115189 especially injectable and spray pharmaceutical formulations. |
| 06/17/2004 | US20040115181 Composition for transmucosal adminstration containing conenzyme q as the active ingredient |
| 06/17/2004 | CA2507763A1 Fused 1,3-dihydro-imidazole ring compounds |
| 06/17/2004 | CA2507011A1 Phosphoantigens for regulating an immune response |
| 06/17/2004 | CA2506965A1 Use of levocetirizine for the treatment of persistent allergic rhinitis |
| 06/17/2004 | CA2485957A1 Protease inhibitor |
| 06/17/2004 | CA2453387A1 Compositions and methods related to nitrotyrosine-containing compounds as antigenic agents |
| 06/16/2004 | EP1428832A2 Peptide and O-glycan inhibitors of selectin mediated inflammation |
| 06/16/2004 | EP1428820A1 Non-imidazole alkylamines as histamine H-3-receptor ligands and their therapeutic applications |
| 06/16/2004 | EP1428536A1 Remedies or preventives for allergic diseases comprising processed peanut seed coat |
| 06/16/2004 | EP1428524A1 Pulmonary delivery of aerosolized medicaments |
| 06/16/2004 | EP1427857A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |
| 06/16/2004 | EP1427841A2 Nucleic acid-associated proteins |
| 06/16/2004 | EP1427806A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 06/16/2004 | EP1427755A2 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies |
| 06/16/2004 | EP1427753A2 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications |
| 06/16/2004 | EP1427730A1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments |
| 06/16/2004 | EP1427722A2 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression |
| 06/16/2004 | EP1427708A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 06/16/2004 | EP1427462A1 Method for inducing selectively suppressed immune response |
| 06/16/2004 | EP1427457A1 Medical devices containing rapamycin analogs |
| 06/16/2004 | EP1427445A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules |
| 06/16/2004 | EP1427441A2 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder |
| 06/16/2004 | EP1427434A2 Anti-inflammatory agent |
| 06/16/2004 | EP1427428A2 Apoptosis-mimicking natural vesicles and use thereof in medical treatment |
| 06/16/2004 | EP1427427A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/16/2004 | EP1427405A2 Inflammation-inhibiting compounds |
| 06/16/2004 | EP1427396A1 Dosage forms having prolonged active ingredient release |
| 06/16/2004 | EP1427395A1 Stabilization of active agents by formulation into nanoparticulate form |
| 06/16/2004 | EP1427349A2 Interleukin-12 as a veterinary vaccine adjuvant |
| 06/16/2004 | EP1351958B1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 06/16/2004 | EP1339719B1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 06/16/2004 | EP1255751B1 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors |
| 06/16/2004 | EP1246839B1 Depsipeptide and congeners thereof for use as immunosuppressants |
| 06/16/2004 | EP1244643B1 Tryptase inhibitors |
| 06/16/2004 | EP1235777B1 Vitamin d analogues |
| 06/16/2004 | EP1194411B1 Benzoylpyridazines |
| 06/16/2004 | EP1171140B1 Treatment of hypersensitivity reaction disorders |
| 06/16/2004 | EP1147117B1 Immunological adjuvant compounds |
| 06/16/2004 | EP1144425B1 Derivatives of monosaccharides as cell adhesion inhibitors |
| 06/16/2004 | EP1089963B1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 06/16/2004 | EP1071658B1 Btk inhibitors and methods for their identification and use |
| 06/16/2004 | EP1064942B1 Sustained release preparation of a macrolide |
| 06/16/2004 | EP1027053B1 Method of preventing nephrotoxicity caused by cyclosporins or tacrolimus |
| 06/16/2004 | EP0986381B1 Use of diterpenes like hypoestoxides for the manufacture of a medicament for immunosuppression, anticancer and antiviral treatment |
| 06/16/2004 | EP0979079B1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 06/16/2004 | EP0817635B1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system |
| 06/16/2004 | EP0807105B1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists |
| 06/16/2004 | EP0787003B1 Animal model system for the testing of drug candidates for the treatment of leukemia or hiv |
| 06/16/2004 | EP0667908B1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases |
| 06/16/2004 | CN1505678A Lactic acid bacteria as agents for treating and preventing allergy |
| 06/16/2004 | CN1505640A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/16/2004 | CN1505636A Pharmaceutically active uridine esters |
| 06/16/2004 | CN1505630A Pyrazolo[1,5-a]pyridines and medicaments containing thereof |
| 06/16/2004 | CN1505627A Cyclic amp-specific phosphodiesterase inhibitors |
| 06/16/2004 | CN1505626A Novel benzylpiperidine compound |
| 06/16/2004 | CN1505618A Dimeric isoflavones |
| 06/16/2004 | CN1505617A Peptides as met-ap2 inhibitors |
| 06/16/2004 | CN1505603A Substituted benzoic ac id derivatives exhibiting nf-ª—b inhibiting activity |
| 06/16/2004 | CN1505537A Disease prevention by reactivation of the thymus |
| 06/16/2004 | CN1505526A Compositions and methods for wt1 specific immunotherapy |
| 06/16/2004 | CN1505524A Immunopotentiators |
| 06/16/2004 | CN1505522A Stimulation of thymus for vaccination development |
| 06/16/2004 | CN1505509A Method for treating allergies using substituted pyrazoles |
| 06/16/2004 | CN1505505A Composition for administration to mucosa and containing coenzyme Q as active ingredient |
| 06/16/2004 | CN1504752A Vaughan Tristan J. |
| 06/16/2004 | CN1504462A Pyrimidinyl derivatives as interleukin inhibitors |
| 06/16/2004 | CN1504453A 1,5-double substituted anthraquinone derivative, synthetic method and uses thereof |
| 06/16/2004 | CN1504233A Lucid ganoderma oral liquid |
| 06/16/2004 | CN1504228A Potherb tea powder capable of improving immunity and promoting immunity reestablishment of AIDS patients |
| 06/16/2004 | CN1504194A Gen-seng drop pill for promoting immunological function |
| 06/16/2004 | CN1153771C Benzofuran-[3,4-f] quinoline derivatives, combination containing the same and application thereof |
| 06/16/2004 | CN1153770C Substitued nitrogen heterocyclic ring as inhibitors of P38 protein kinase |
| 06/16/2004 | CN1153577C Phospholipid capsule preparation |
| 06/16/2004 | CN1153569C Use of fumaric acid derivatives |
| 06/15/2004 | US6750350 Therapy for sexual disorders |
| 06/15/2004 | US6750253 Aminobenzophenones as inhibitors of il-1β and tnf-α |
| 06/15/2004 | US6750239 Useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 06/15/2004 | US6750231 Skin disorders; gastrointestinal disorders |
| 06/15/2004 | US6750217 Anticancer agents; cardiovascular disorders; kinase inhibitor |
| 06/15/2004 | US6750210 Formulation containing novel anti-inflammatory androstane derivative |